Roeland Nusse Power - 23 Aug 2021 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
Director
Signature
/s/ Brenda S. Furlow as Attorney-in-Fact for Roeland Nusse pursuant to Power of Attorney previously filed.
Issuer symbol
TECH
Transactions as of
23 Aug 2021
Net transactions value
-$1,644,665
Form type
4
Filing time
25 Aug 2021, 17:13:06 UTC
Next filing
01 Nov 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Options Exercise $281,400 +4,000 +59% $70.35 10,765 23 Aug 2021 Direct
transaction TECH Common Stock Sale $1,926,065 -4,000 -37% $481.52* 6,765 23 Aug 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Stock Option (right to buy) Options Exercise $0 -4,000 -100% $0.000000* 0 23 Aug 2021 Common Stock 4,000 $70.35 Direct
holding TECH Stock Option (right to buy) 4,000 23 Aug 2021 Common Stock 4,000 $87.39 Direct
holding TECH Stock Option (right to buy) 4,000 23 Aug 2021 Common Stock 4,000 $91.78 Direct
holding TECH Stock Option (right to buy) 4,260 23 Aug 2021 Common Stock 4,260 $87.34 Direct
holding TECH Stock Option (right to buy) 3,985 23 Aug 2021 Common Stock 3,985 $101.19 Direct
holding TECH Stock Option (right to buy) 3,125 23 Aug 2021 Common Stock 3,125 $125.05 Direct
holding TECH Stock Option (right to buy) 1,898 23 Aug 2021 Common Stock 1,898 $179.84 Direct
holding TECH Stock Option (right to buy) 2,011 23 Aug 2021 Common Stock 2,011 $201.64 Direct
holding TECH Stock Option (right to buy) 1,507 23 Aug 2021 Common Stock 1,507 $255.69 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests on the earlier of the one year anniversary of the grant date (10/29/2020) or the date of Bio-Techne's 2021 annual meeting of shareholders.